摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

7β,19-dihydroxy-3,3-(ethylenedioxy)-5-androsten-17β-yl acetate | 233768-88-2

分子结构分类

中文名称
——
中文别名
——
英文名称
7β,19-dihydroxy-3,3-(ethylenedioxy)-5-androsten-17β-yl acetate
英文别名
[(7R,8R,9S,10S,13S,14S,17S)-7-hydroxy-10-(hydroxymethyl)-13-methylspiro[1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthrene-3,2'-1,3-dioxolane]-17-yl] acetate
7β,19-dihydroxy-3,3-(ethylenedioxy)-5-androsten-17β-yl acetate化学式
CAS
233768-88-2
化学式
C23H34O6
mdl
——
分子量
406.519
InChiKey
LLWJGZOWSXHZTE-NTNVJIBLSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.7
  • 重原子数:
    29
  • 可旋转键数:
    3
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.87
  • 拓扑面积:
    85.2
  • 氢给体数:
    2
  • 氢受体数:
    6

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    7β,19-dihydroxy-3,3-(ethylenedioxy)-5-androsten-17β-yl acetate 在 palladium on activated charcoal 吡啶chromium(VI) oxide氢氧化钾 、 sodium tetrahydroborate 、 cerium(III) chloride 、 氢气三乙基硼氢化锂对甲苯磺酸 作用下, 以 四氢呋喃甲醇二氯甲烷丙酮 为溶剂, 4.0~65.0 ℃ 、101.33 kPa 条件下, 反应 130.75h, 生成 5-二氢-19-去甲睾酮
    参考文献:
    名称:
    7α-Iodo and 7α-Fluoro Steroids as Androgen Receptor-Mediated Imaging Agents
    摘要:
    We have synthesized several 7 alpha-fluoro (F) and 7 alpha-iodo (I) analogues of 5 alpha-dihydrotestosterone (5 alpha-DHT) and 19-nor-5 alpha-dihydrotestosterone (5 alpha-NDHT) and tested them for binding to the androgen receptor and for their biological activity in;an in vitro assay with cells that have been engineered to respond to androgens. The relative binding affinity to the androgen receptor determined in competition assays showed that in the androstane series the fluoro steroids have the highest affinity and that F-17 alpha-CH3-DHT (4) has a higher affinity than 5 alpha-DHT. All other steroids were somewhat less potent than 5 alpha-DHT with F-DHT (2) = I-17 alpha-CH3-DHT (3) greater than or equal to F-NDHT (6) > F-17 alpha-CH3-NDHT (8) = I-DHT (1) greater than or equal to I-NDHT (5) > I-17 alpha-CH3-NDHT (7). The relative biological activity in cells transfected with the androgen receptor and an androgen responsive reporter gene is 4 much greater than 5 alpha-DHT > 2 > 6 > 3 greater than or equal to 1 greater than or equal to 8 greater than or equal to 5 > 7. The iodinated compound, I-17 alpha-CH3-DHT (3), with the highest binding activity was synthesized labeled with I-125 and was shown to bind with high affinity, K-a = 1.9 x 10(10) L/mol, and low nonspecific binding to the androgen receptor in rat prostatic cytosol. However, when radiolabeled [I-125]-17 alpha-CH3-DHT ([I-125]3) was injected into castrated male rats, it showed very poor androgen receptor-mediated uptake into the rat prostate. This was unexpected in light of its superior receptor binding properties and its protection by the 17 alpha-methyl group from metabolic oxidation at C-17. However, the biological potency of I-17 alpha-CH3-DHT (3) was not as high as would have been expected. When I-DHT (1) and I-17 alpha-CH3-DHT (3) were incubated in aqueous media at 37 degrees C they rapidly decomposed, but they were stable at 0 degrees C. The fluorinated analogue 4 treated similarly at 37 degrees C was completely stable. The products of the decomposition reaction of I-DHT (1) at 37 degrees C were identified as iodide and principally 17 beta-hydroxy-5 alpha-androst-7-en-3-one. The temperature dependence of this elimination reaction explains the inconsistency between the high binding to the androgen receptor (measured at 0 degrees C) and the low biological activity, as well as the poor androgen receptor mediated concentration in vivo. The fluorinated analogue F-17 alpha-CH3-DHT (4) has both high affinity for the androgen receptor and high stability in aqueous media. Of the compounds tested, 4 has the highest affinity for the androgen receptor as well as the highest androgenic activity. Thus it is likely that F-17 alpha-CH3-DHT 4 labeled with F-18 will be an excellent receptor-mediated diagnostic imaging agent.
    DOI:
    10.1021/jm990064o
  • 作为产物:
    描述:
    19-(tert-butyldiphenylsiloxy)-3,3-(ethylenedioxy)-7β-hydroxyandrost-5-en-17β-yl acetate四丁基氟化铵 作用下, 以 四氢呋喃 为溶剂, 反应 24.0h, 以81%的产率得到7β,19-dihydroxy-3,3-(ethylenedioxy)-5-androsten-17β-yl acetate
    参考文献:
    名称:
    7α-Iodo and 7α-Fluoro Steroids as Androgen Receptor-Mediated Imaging Agents
    摘要:
    We have synthesized several 7 alpha-fluoro (F) and 7 alpha-iodo (I) analogues of 5 alpha-dihydrotestosterone (5 alpha-DHT) and 19-nor-5 alpha-dihydrotestosterone (5 alpha-NDHT) and tested them for binding to the androgen receptor and for their biological activity in;an in vitro assay with cells that have been engineered to respond to androgens. The relative binding affinity to the androgen receptor determined in competition assays showed that in the androstane series the fluoro steroids have the highest affinity and that F-17 alpha-CH3-DHT (4) has a higher affinity than 5 alpha-DHT. All other steroids were somewhat less potent than 5 alpha-DHT with F-DHT (2) = I-17 alpha-CH3-DHT (3) greater than or equal to F-NDHT (6) > F-17 alpha-CH3-NDHT (8) = I-DHT (1) greater than or equal to I-NDHT (5) > I-17 alpha-CH3-NDHT (7). The relative biological activity in cells transfected with the androgen receptor and an androgen responsive reporter gene is 4 much greater than 5 alpha-DHT > 2 > 6 > 3 greater than or equal to 1 greater than or equal to 8 greater than or equal to 5 > 7. The iodinated compound, I-17 alpha-CH3-DHT (3), with the highest binding activity was synthesized labeled with I-125 and was shown to bind with high affinity, K-a = 1.9 x 10(10) L/mol, and low nonspecific binding to the androgen receptor in rat prostatic cytosol. However, when radiolabeled [I-125]-17 alpha-CH3-DHT ([I-125]3) was injected into castrated male rats, it showed very poor androgen receptor-mediated uptake into the rat prostate. This was unexpected in light of its superior receptor binding properties and its protection by the 17 alpha-methyl group from metabolic oxidation at C-17. However, the biological potency of I-17 alpha-CH3-DHT (3) was not as high as would have been expected. When I-DHT (1) and I-17 alpha-CH3-DHT (3) were incubated in aqueous media at 37 degrees C they rapidly decomposed, but they were stable at 0 degrees C. The fluorinated analogue 4 treated similarly at 37 degrees C was completely stable. The products of the decomposition reaction of I-DHT (1) at 37 degrees C were identified as iodide and principally 17 beta-hydroxy-5 alpha-androst-7-en-3-one. The temperature dependence of this elimination reaction explains the inconsistency between the high binding to the androgen receptor (measured at 0 degrees C) and the low biological activity, as well as the poor androgen receptor mediated concentration in vivo. The fluorinated analogue F-17 alpha-CH3-DHT (4) has both high affinity for the androgen receptor and high stability in aqueous media. Of the compounds tested, 4 has the highest affinity for the androgen receptor as well as the highest androgenic activity. Thus it is likely that F-17 alpha-CH3-DHT 4 labeled with F-18 will be an excellent receptor-mediated diagnostic imaging agent.
    DOI:
    10.1021/jm990064o
点击查看最新优质反应信息

同类化合物

()-2-(5-甲基-2-氧代苯并呋喃-3(2)-亚乙基)乙酸乙酯 (甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (反式)-4-壬烯醛 (双(2,2,2-三氯乙基)) (乙腈)二氯镍(II) (乙基N-(1H-吲唑-3-基羰基)ethanehydrazonoate) (βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (±)17,18-二HETE (±)-辛酰肉碱氯化物 (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (s)-2,3-二羟基丙酸甲酯 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 ([2-(萘-2-基)-4-氧代-4H-色烯-8-基]乙酸) ([1-(甲氧基甲基)-1H-1,2,4-三唑-5-基](苯基)甲酮) (Z)-5-辛烯甲酯 (Z)-4-辛烯醛 (Z)-4-辛烯酸 (Z)-3-[[[2,4-二甲基-3-(乙氧羰基)吡咯-5-基]亚甲基]吲哚-2--2- (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-(-)-5'-苄氧基苯基卡维地洛 (S)-(-)-2-(α-(叔丁基)甲胺)-1H-苯并咪唑 (S)-(-)-2-(α-甲基甲胺)-1H-苯并咪唑 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-(+)-5,5'',6,6'',7,7'',8,8''-八氢-3,3''-二叔丁基-1,1''-二-2-萘酚,双钾盐 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-盐酸沙丁胺醇 (S)-溴烯醇内酯 (S)-氨氯地平-d4 (S)-氨基甲酸酯β-D-O-葡糖醛酸 (S)-8-氟苯并二氢吡喃-4-胺 (S)-7,7-双[(4S)-(苯基)恶唑-2-基)]-2,2,3,3-四氢-1,1-螺双茚满 (S)-4-(叔丁基)-2-(喹啉-2-基)-4,5-二氢噁唑 (S)-4-氯-1,2-环氧丁烷 (S)-3-(((2,2-二氟-1-羟基-7-(甲基磺酰基)-2,3-二氢-1H-茚满-4-基)氧基)-5-氟苄腈 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-3-(2-(二氟甲基)吡啶-4-基)-7-氟-3-(3-(嘧啶-5-基)苯基)-3H-异吲哚-1-胺 (S)-2-(环丁基氨基)-N-(3-(3,4-二氢异喹啉-2(1H)-基)-2-羟丙基)异烟酰胺 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-2-N-Fmoc-氨基甲基吡咯烷盐酸盐 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (SP-4-1)-二氯双(喹啉)-钯 (SP-4-1)-二氯双(1-苯基-1H-咪唑-κN3)-钯